Combination of Low-Dose, Short-Course Mycophenolate Mofetil With Cyclosporine and Methotrexate for Graft-Versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant

MLA

Mani Ramzi, et al. “Combination of Low-Dose, Short-Course Mycophenolate Mofetil With Cyclosporine and Methotrexate for Graft-Versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant.” Experimental and Clinical Transplantation, vol. 19, Dec. 2021, pp. 1328–33. EBSCOhost, https://doi.org/10.6002/ect.2020.0004.

APA

Mani Ramzi, Hourvash Haghighinejad, Nasrin Namdari, & Shirin Haghighat. (2021). Combination of Low-Dose, Short-Course Mycophenolate Mofetil With Cyclosporine and Methotrexate for Graft-Versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant. Experimental and Clinical Transplantation, 19, 1328–1333. https://doi.org/10.6002/ect.2020.0004

Chicago

Mani Ramzi, Hourvash Haghighinejad, Nasrin Namdari, and Shirin Haghighat. 2021. “Combination of Low-Dose, Short-Course Mycophenolate Mofetil With Cyclosporine and Methotrexate for Graft-Versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant.” Experimental and Clinical Transplantation 19 (December): 1328–33. doi:10.6002/ect.2020.0004.